Quantitative Pathology Imaging Market

Quantitative Pathology Imaging Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment; 2017 – 2027

  • Ongoing
  • August 2020
  • REP-GB-5041
Quantitative Pathology Imaging Market

  • US$5,000
  • US$7,500
  • US$10,000

This Quantitative Pathology Imaging market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Quantitative Pathology Imaging market.

Quantitative pathology imaging systems visualize, analyze, quantify, and phenotype immune cells in situ in FFPE (formalin-fixed paraffin-embedded) tissue sections. These imaging systems are able to screen tumor tissue microarrays (TMA tumors). The available quantitative pathology systems in the market can help in analyzing a basic understanding into the part of resistant cells inside strong tumors and the tumor microenvironment. The recently launched Vectra 3.0 (PerkinElmer) fuses 10x entire slide imaging and the Phenochart entire slide watcher, enabling analysts to comment on and explore slides with intelligent interfaces to better distinguish the area of interest for accurate and detailed multispectral procurement.

The multiplexing capacity of recently propelled quantitative pathology imaging systems empowers distinguishing identification and evaluation of different biomarkers and uncovers spatial setting inside a computerized work process to help specialists in settling on more sagacious choices.

The quantitative pathology imaging systems detects and measures multiple weakly expressed and overlapping biomarkers and also include an integrated inForm analysis software which automatically identifies specific types of tissues using patented user-trainable algorithms developed to recognize morphological patterns.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Quantitative Pathology Imaging System Market: Drivers and Restraints

Rising incidence of various types of cancer along with the new lifestyle patterns and growing geriatric and matured population energies the overall growth of quantitative pathology imaging system market. Traditionally present quantitative pathology imaging systems have vital limits that do not allow wide-ranging and exhaustive assessment of immune cells. The newly available quantitative pathology imaging systems enable accurate valuation of visualization characteristics of immune or tumor cells, and provide reliable and right identification of tumor microenvironment. Recently launched quantitative pathology imaging systems from top manufacturers empower pathologists and oncologists guiding immuno-oncology research to advance a deeper understanding of the disease mechanisms allied to advanced immunotherapy methods. Also, there is an increase in demand commercially due to limited manufacturing capacity for quantitative pathology imaging systems, which is going to drive the growth of the market during the forecast period.  Increasing research on immune cells within solid tumors is also another factor driving towards the rapid advancement of technology. For example, an European laboratory (HISTALIM) to embrace the automated quantitative pathology imaging system (Vectra Polaris) manufactured by PerkinElmer, Inc. which permits researchers or experts to analyze and examine up to seven bio markers on single slide. All these factors are contributing to the robust growth of the quantitative pathology imaging system market. Truncated approachability about the quantitative pathology imaging systems and not getting full-scale acceptances among the healthcare specialist’s acts as a restraint for quantitative pathology imaging systems market. Also, lack of availability of quantitative pathology imaging systems in the international market may act as a restraint. Newly launched quantitative pathology imaging systems in the international market is still considered as an innovative technology for which reimbursements are not available totally, which act as a restraint to overall growth during the forecast period.

Quantitative pathology Imaging System Market: Market Overview

Quantitative pathology imaging systems have witnessed a steady growth because of preventive measures of top healthcare systems in developed countries and governments. The organizations are for the most part concentrating on consistence with natural laws and controls of new medical devices despite the fact that it could be costly in light of the fact that inability to follow these laws and directions could subject to the critical risk of quantitative pathology imaging systems. Research and development endeavors are centered predominantly on enhancing this framework and putting resources into clinical examinations to additionally exhibit the viability of programmed quantitative pathology imaging systems over the accessible conventional systems. Since quantitative pathology imaging system is a new innovation, many organizations are concentrating on broad deals constrain and advertising. The growth is expected with a healthy CAGR during the forecast period.

Quantitative pathology Imaging System Market: Region-Wise Overview

The global quantitative pathology imaging system market is segmented into seven regions mainly, North America, Eastern Europe, Western Europe, Latin America, Asia-Pacific, Japan and the Middle East and Africa. In the current scenario, North America is dominating in the global quantitative pathology imaging systems market due to the high presence of top manufacturers. Mainly the U.S. market occupies the maximum share in North America due to increased awareness and usage of advanced technology. It is followed by the Europe and Asia-Pacific regions due to rising acceptance of the quantitative pathology imaging systems moderately. The growth in the Middle East and Africa is low when compared to the developing countries due to less availability and acceptability of quantitative pathology imaging systems.

Quantitative pathology Imaging System Market: Key Participants

The key participants in the quantitative pathology imaging system market are Leica Microsystems, PerkinElmer Inc. and Diagnostic Instruments, Inc. The organizations are essentially concentrating on the solid line of distribution channels and advertising to increase the expansion of quantitative pathology imaging systems in the international market. The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Quantitative Pathology Imaging Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Quantitative Pathology Imaging System Market: Segmentation

Segmentation Based on Component Type

  • Instruments
  • Software
  • Services

Segmentation Based on End User

  • Hospitals
  • Clinics
  • Pathology Diagnostic Laboratories
  • Research Institutes

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Quantitative Pathology Imaging Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Quantitative Pathology Imaging Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Akshay Godge

Akshay Godge

Client Partner - Global Business Development

Our Clients

Request Sample Request customization Request Methodology